Profile
Andrew T.
Drechsler worked as Principal at Coopers & Lybrand LLP from 1994 to 1997.
He was Controller at i-STAT Corp.
and Biomatrix, Inc. from 1997 to 2005.
He served as Chief Financial Officer at Valera Pharmaceuticals, Inc. from 2005 to 2007, at VaxInnate Corp.
from 2007 to 2012, at Insmed, Inc. from 2014 to 2017, and at Provention Bio, Inc. from 2017 to 2021.
He was Controller at Abbott Laboratories and Independent Director at Baudax Bio, Inc. Mr. Drechsler completed undergraduate studies at Villanova University in 1994.
Former positions of Andrew Drechsler
| Companies | Position | End |
|---|---|---|
| PROVENTION BIO, INC. | Director of Finance/CFO | 01/12/2021 |
| INSMED INCORPORATED | Director of Finance/CFO | 01/03/2017 |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Director of Finance/CFO | 01/11/2012 |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders | Director of Finance/CFO | 18/04/2007 |
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic products | Comptroller/Controller/Auditor | 01/01/2005 |
Training of Andrew Drechsler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic products | Health Technology |
Biomatrix, Inc.
Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders | Health Technology |
Coopers & Lybrand LLP
Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
Baudax Bio, Inc.
Baudax Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for acute care settings | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- Andrew Drechsler
















